Home/CytexOrtho/Adam Mathis
AM

Adam Mathis

Chief Financial Officer

CytexOrtho

Therapeutic Areas

CytexOrtho Pipeline

DrugIndicationPhase
Acellular Hip Implant for Cartilage RepairOsteoarthritis / Cartilage Defects of the HipPhase 1